| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
28,429 |
24,987 |
$606K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,140 |
5,125 |
$232K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,526 |
2,344 |
$166K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
921 |
785 |
$137K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
3,080 |
2,015 |
$114K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,418 |
3,955 |
$108K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,886 |
3,203 |
$93K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,170 |
1,043 |
$88K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,433 |
5,414 |
$88K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,566 |
1,343 |
$74K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
717 |
681 |
$73K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,683 |
3,540 |
$73K |
| J3490 |
Unclassified drugs |
13,934 |
6,547 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,721 |
1,539 |
$66K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,158 |
3,432 |
$65K |
| 80053 |
Comprehensive metabolic panel |
10,167 |
8,710 |
$62K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,968 |
11,173 |
$58K |
| 0270 |
|
24,669 |
10,599 |
$49K |
| Z7502 |
|
1,261 |
1,238 |
$47K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
999 |
946 |
$46K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,001 |
846 |
$45K |
| 71045 |
Radiologic examination, chest; single view |
5,277 |
4,717 |
$44K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,206 |
1,025 |
$44K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,089 |
930 |
$42K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,473 |
2,148 |
$41K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,120 |
3,302 |
$38K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
8,436 |
4,727 |
$36K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,586 |
1,404 |
$36K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
6,027 |
4,938 |
$34K |
| 99199 |
Unlisted special service, procedure or report |
746 |
713 |
$33K |
| 83690 |
|
7,840 |
6,680 |
$31K |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
4,647 |
4,265 |
$27K |
| 84484 |
|
4,078 |
3,100 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,473 |
1,085 |
$18K |
| 81025 |
|
6,017 |
5,252 |
$18K |
| 81001 |
|
8,602 |
7,517 |
$16K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,436 |
2,927 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,793 |
1,357 |
$14K |
| 0250 |
|
5,284 |
3,427 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,940 |
1,566 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,718 |
2,249 |
$11K |
| Z7610 |
|
907 |
567 |
$11K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,211 |
1,989 |
$11K |
| 0271 |
|
4,662 |
3,704 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,346 |
1,245 |
$7K |
| 71046 |
Radiologic examination, chest; 2 views |
520 |
471 |
$7K |
| 0272 |
|
4,397 |
3,927 |
$6K |
| 87040 |
|
892 |
410 |
$5K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
40 |
39 |
$4K |
| 83605 |
|
698 |
555 |
$4K |
| 73562 |
|
227 |
205 |
$4K |
| 73610 |
|
200 |
182 |
$3K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
545 |
403 |
$3K |
| 83880 |
|
202 |
183 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
668 |
574 |
$3K |
| 90715 |
|
112 |
96 |
$3K |
| 87186 |
|
632 |
545 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
461 |
377 |
$2K |
| 85610 |
|
912 |
824 |
$2K |
| 73030 |
|
119 |
102 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
46 |
39 |
$2K |
| 73630 |
|
110 |
106 |
$2K |
| 82962 |
|
1,376 |
931 |
$2K |
| 87070 |
|
636 |
563 |
$2K |
| 99406 |
|
262 |
234 |
$2K |
| 94760 |
|
316 |
274 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
4,063 |
3,513 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
216 |
123 |
$1K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
302 |
238 |
$1K |
| 87420 |
|
369 |
340 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
51 |
40 |
$1K |
| 85379 |
|
177 |
156 |
$1K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
32 |
27 |
$1K |
| 85730 |
|
311 |
291 |
$1K |
| 85027 |
|
719 |
617 |
$621.42 |
| 0636 |
|
245 |
191 |
$558.77 |
| 0011A |
|
12 |
12 |
$480.00 |
| Z9725 |
|
13 |
13 |
$390.00 |
| 87088 |
|
92 |
84 |
$375.57 |
| 99070 |
|
120 |
68 |
$333.98 |
| 84702 |
|
41 |
37 |
$292.10 |
| 73130 |
|
16 |
15 |
$278.53 |
| 0301 |
|
174 |
67 |
$255.80 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
60 |
57 |
$214.89 |
| 73110 |
|
13 |
12 |
$209.95 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16 |
13 |
$173.60 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16 |
13 |
$173.50 |
| 74018 |
|
14 |
13 |
$150.71 |
| J2060 |
Injection, lorazepam, 2 mg |
27 |
24 |
$135.89 |
| 80076 |
|
27 |
27 |
$122.88 |
| 29125 |
|
48 |
48 |
$118.25 |
| 87184 |
|
44 |
41 |
$117.12 |
| 86901 |
|
41 |
37 |
$116.57 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
32 |
27 |
$116.04 |
| A4649 |
Surgical supply; miscellaneous |
279 |
132 |
$108.21 |
| 96376 |
|
70 |
57 |
$105.12 |
| 86900 |
|
41 |
37 |
$93.11 |
| 87205 |
|
47 |
44 |
$79.86 |
| 82947 |
|
30 |
29 |
$57.28 |
| 82550 |
|
14 |
12 |
$44.43 |
| A4657 |
Syringe, with or without needle, each |
13 |
13 |
$26.56 |
| A4215 |
Needle, sterile, any size, each |
24 |
19 |
$3.15 |
| 0305 |
|
77 |
59 |
$0.00 |
| 0324 |
|
18 |
17 |
$0.00 |
| 0306 |
|
28 |
12 |
$0.00 |
| 0320 |
|
25 |
20 |
$0.00 |